Search Results
MY FIRST 100 DAYS AS LLS PRESIDENT & CEO
Dear Friends,
I’m just over 100 days into my new role as President & CEO of The Leukemia & Lymphoma Society (LLS) and I want to take this moment to say how grateful and proud I am to work alongside all of you in service of blood cancer patients and their families. It’s been great meeting many of you as I travel to our regions and meet with departments throughout the country. And I look forward to meeting many more of you in the months ahead.
#ASH18: Beating AML
Sunday marked a significant milestone for The Leukemia & Lymphoma Society (LLS) and the patients we help. Here at the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, a conference attended by more than 30,000 scientists from around the world, we unveiled the first results from our groundbreaking precision medicine Beat AML Master Clinical Trial. To date, more than 356 patients have been screened for this trial.
Ultra-Endurance Athlete Takes on 1000-Mile Iconic Race for Cancer Cures
52-year-old Steve Cannon from Iowa refers to himself as an adventurer, but when you look at his track record of accomplishments, media, spectators and fans across the country refer to him as a beast. He was the first-ever athlete to run around Lake Michigan and averaged a marathon a day for 40 straight days totaling 1,037 miles. He’s also completed a 350-mile bike ride and took on the world’s longest Kayak race – just to list a few.
Forbes Women’s Summit 2019: LLS’s Chief Medical Officer Joins Women In Leading the Way
More than 400 women from diverse backgrounds in business, entertainment, fashion, media, healthcare, science and finance came together this week to inspire and encourage one another at the 2019 Forbes Women’s Summit at Pier 60 Chelsea Piers in New York City.
The attendees engaged in animated discussions about how women are changing the world while still fighting to overcome obstacles they face in the workforce and on the world stage.
A phase 1 study of VIPER-101, a CD5-edited dual population chimeric antigen receptor cell therapy, to enhance immunotherapy against T-cell non-Hodgkin lymphoma
In October 2023, LLS made an equity investment in Vittoria to "Support Clinical Development of VIPER-101, a CAR-T Cell Therapy for T-cell lymphomas."
5 Ways to Support Blood Cancer Patients
Have you ever Googled, “what to do for someone with cancer”?
Have you felt helpless or frustrated when trying to think of something meaningful to offer them or do for them? You want them to know you’re ready to help, but don’t know how to help.
We’re often told to just ask the person what they need. But the truth is, they probably don’t know what they need. And figuring it out can be tough on top of all the new questions that come with their diagnosis.
So now what?
Celebrating Our Amazing Volunteers This National Intern Day
I can’t think of better partners to join us in the fight against cancer than the future nonprofit and healthcare executives of the world. Whether students, recent grads or professionals transitioning to a new career path, LLS embraces the support of volunteer interns throughout the year as we work tirelessly toward a world without blood cancer.
21st Century Cures Act Victory
As Vice President of LLS’s Office of Public Policy, Bernadette O’Donoghue leads strategic public policy development at the federal and state levels, providing input from patients to help improve access to care and accelerate cures.
This week was a monumental victory for cancer patients. The 21st Century Cures Act, which will significantly speed access to new lifesaving therapies, was signed into a law. Now, cancer patients, survivors and their families are closer to improved diagnostics, treatments, and ultimately, cures.
Outrunning Cancer: 27-Year-Old Survivor Completes First Marathon
Lara Snead has always been a runner. A competitor since high school, Lara gradually quickened her pace and increased her stamina to the half-marathon distance.
Last June, at age 27, with a winning bib number from the lottery happily in hand, she set her sights on her first Marine Corps Marathon.
During her early training, her body sent her a signal. Chest pain and fatigue would be the first signs of a cancerous tumor growing around her sternum, and an enlarged lymph node near her collarbone confirmed it was Hodgkin lymphoma. Her first marathon would have to wait.
Ask the Doctor Part 3: Five Questions about Myeloma
Myeloma Survivor, Sharon Clark Talks to Dr. Nichols about the Latest in Myeloma Research and Treatment